Eye Journal
Assessing retinal ganglion cell damage – (Eye 31, 209 (February 2017))
Assessing retinal ganglion cell damage Eye 31, 209 (February 2017). doi:10.1038/eye.2016.295 Authors: C A Smith, J R Vianna & B C Chauhan
Protecting retinal ganglion cells – (Eye 31, 218 (February 2017))
Protecting retinal ganglion cells Eye 31, 218 (February 2017). doi:10.1038/eye.2016.299 Authors: T Z Khatib & K R Martin
Biomarkers for glaucoma: from the lab to the clinic – (Eye 31, 225 (February 2017))
Biomarkers for glaucoma: from the lab to the clinic Eye 31, 225 (February 2017). doi:10.1038/eye.2016.300 Authors: N Von Thun Und Hohenstein-Blaul, S Kunst, N Pfeiffer & F H Grus
Fingolimod: therapeutic mechanisms and ocular adverse effects – (Eye 31, 232 (February 2017))
Fingolimod: therapeutic mechanisms and ocular adverse effects Eye 31, 232 (February 2017). doi:10.1038/eye.2016.258 Authors: P Mandal, A Gupta, W Fusi-Rubiano, P A Keane & Y Yang
Uveal melanoma: relatively rare but deadly cancer – (Eye 31, 241 (February 2017))
Uveal melanoma: relatively rare but deadly cancer Eye 31, 241 (February 2017). doi:10.1038/eye.2016.275 Authors: S Kaliki & C L Shields